Cargando…

Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9

Circulation tumor cells (CTCs) play an important role in metastasis and highly correlate with cancer progression; thus, CTCs could be considered as a powerful diagnosis tool. Our previous studies showed that the number of CTCs could be utilized for recurrence prediction in colorectal cancer (CRC); h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Hsueh-Yao, Yang, Chih-Yung, Yeh, Ping-Hao, Hsu, Chun-Jieh, Chang, Lu-Wei, Chan, Wei-Jen, Lin, Chien-Ping, Lyu, You-You, Wu, Wei-Cheng, Lee, Chun-Wei, Wu, Jen-Kuei, Jiang, Jeng-Kai, Tseng, Fan-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151024/ https://www.ncbi.nlm.nih.gov/pubmed/34068719 http://dx.doi.org/10.3390/cells10051149

Ejemplares similares

Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection
por: Chen, Jia-Yang, et al.
Publicado: (2016)

Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer()
por: Zheng, Xiumei, et al.
Publicado: (2017)

Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
por: Lertkhachonsuk, Arb‐aroon, et al.
Publicado: (2020)

EGFR/MET promotes hepatocellular carcinoma metastasis by stabilizing tumor cells and resisting to RTKs inhibitors in circulating tumor microemboli
por: Song, Shouyang, et al.
Publicado: (2022)

Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions
por: Mascalchi, Mario, et al.
Publicado: (2017)

CEA Decline Predicts Tumor Regression and Prognosis in Locally Advanced Rectal Cancer Patients with Elevated Baseline CEA
por: Cai, Zerong, et al.
Publicado: (2020)

Amplified intracellular Ca(2+) for synergistic anti-tumor therapy of microwave ablation and chemotherapy
por: Dou, Jian-ping, et al.
Publicado: (2019)

Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer
por: Chen, Yang, et al.
Publicado: (2021)

Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery
por: Yang, Kai-Lin, et al.
Publicado: (2013)

Fusion Protein Vaccines Targeting Two Tumor Antigens Generate Synergistic Anti-Tumor Effects
por: Cheng, Wen-Fang, et al.
Publicado: (2013)

Oesophagus cancer, secondary cardiac tumour, and pulmonary microemboli
por: Tanaka, Yutaka, et al.
Publicado: (2022)

Five common tumor biomarkers and CEA for diagnosing early gastric cancer: A protocol for a network meta-analysis of diagnostic test accuracy
por: Shen, Minghui, et al.
Publicado: (2018)

Anti-CEA-functionalized superparamagnetic iron oxide nanoparticles for examining colorectal tumors in vivo
por: Huang, Kai-Wen, et al.
Publicado: (2013)

New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma
por: Wan, Shanshan, et al.
Publicado: (2019)

Localizing Microemboli within the Rodent Brain through Block-Face Imaging and Atlas Registration
por: McDonald, Matthew W., et al.
Publicado: (2021)

Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients
por: Silvestri, Marco, et al.
Publicado: (2021)

Microemboli-monitoring during the acute phase of ischemic stroke: Is it worth the time?
por: Idicula, Titto T, et al.
Publicado: (2010)

The Synergistic Effect of Chemical Carcinogens Enhances Epstein-Barr Virus Reactivation and Tumor Progression of Nasopharyngeal Carcinoma Cells
por: Fang, Chih-Yeu, et al.
Publicado: (2012)

Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma
por: Wang, Wei, et al.
Publicado: (2016)

CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor
por: Torres, Jacqueline Aparecida, et al.
Publicado: (2023)

Synergistic Antiproliferation of Cisplatin and Nitrated [6,6,6]Tricycle Derivative (SK2) for a Combined Treatment of Oral Cancer Cells
por: Wang, Sheng-Chieh, et al.
Publicado: (2022)

Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy
por: Sheu, Zai-Lin, et al.
Publicado: (2021)

Isoliquiritigenin Inhibits Gastric Cancer Stemness, Modulates Tumor Microenvironment, and Suppresses Tumor Growth through Glucose-Regulated Protein 78 Downregulation
por: Lee, Chien-Hsing, et al.
Publicado: (2022)

Miliary microemboli of the retinal arterioles and choriocapillaris after subcutaneous injection of triamcinolone acetonide
por: Kayikcioglu, Ozcan Rasim, et al.
Publicado: (2018)

Molecular Mechanisms and Animal Models of HBV-Related Hepatocellular Carcinoma: With Emphasis on Metastatic Tumor Antigen 1
por: Li, Yung-Tsung, et al.
Publicado: (2021)

A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer
por: Abdallah, Emne Ali, et al.
Publicado: (2020)

Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor‐positive breast cancer via regulation of the mTOR pathway
por: Hsu, Hui‐Ping, et al.
Publicado: (2022)

Predictive Value of FOLFOX-Based Regimen, Long Interval, Hemoglobin Levels and Clinical Negative Nodal Status, and Postchemoradiotherapy CEA Levels for Pathological Complete Response in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy
por: Huang, Chun-Ming, et al.
Publicado: (2020)

The Prognostic Value of Circulating Tumor Cells in Asian Neuroendocrine Tumors
por: Hsieh, Jason Chia-Hsun, et al.
Publicado: (2019)

Role of Tissue Plasminogen Activator for Diffuse Pulmonary Microemboli in Coronavirus Disease 2019 Patient
por: Ghia, Samit, et al.
Publicado: (2021)

In vivo analysis of the origin and characteristics of gaseous microemboli during catheter-mediated irreversible electroporation
por: Groen, Marijn H A, et al.
Publicado: (2020)

Physical Cues in the Microenvironment Regulate Stemness-Dependent Homing of Breast Cancer Cells
por: Chu, Hsueh-Yao, et al.
Publicado: (2020)

A novel classifier based on three preoperative tumor markers predicting the cancer-specific survival of gastric cancer (CEA, CA19-9 and CA72-4)
por: Guo, Jing, et al.
Publicado: (2017)

CEAS: cis-regulatory element annotation system
por: Ji, Xuwo, et al.
Publicado: (2006)

Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy
por: Zhang, Dejun, et al.
Publicado: (2017)

Pretreatment serum interleukin‐1β, interleukin‐6, and tumor necrosis factor‐α levels predict the progression of colorectal cancer
por: Chang, Pei‐Hung, et al.
Publicado: (2016)

Outcomes of 50 Patients With Ewing Sarcoma Family of Tumors Treated at a Single Institution in Taiwan
por: Lee, Chih-Ying, et al.
Publicado: (2016)

Resveratrol and Arsenic Trioxide Act Synergistically to Kill Tumor Cells In Vitro and In Vivo
por: Zhao, Xiao-Yan, et al.
Publicado: (2014)

Revealing the Anti-Tumor Effect of Artificial miRNA p-27-5p on Human Breast Carcinoma Cell Line T-47D
por: Tseng, Chien-Wei, et al.
Publicado: (2012)

CEA TCB: A novel head-to-tail 2:1 T cell bispecific antibody for treatment of CEA-positive solid tumors
por: Bacac, Marina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v1o8ulchonmhdr84043plca3o1